Synthesis and biological evaluation of EC20: a new folate-derived, (99m)Tc-based radiopharmaceutical.
about
Targeting folate receptor alpha for cancer treatmentDevelopment and evaluation of a new modular nanotransporter for drug delivery into nuclei of pathological cells expressing folate receptors.A low molecular weight folate receptor targeted contrast agent for magnetic resonance tumor imaging.Folate receptor-targeted multimodality imaging of ovarian cancer in a novel syngeneic mouse modelAssessment of disease activity in rheumatoid arthritis using a novel folate targeted radiopharmaceutical Folatescan.Design, synthesis, and biological evaluation of theranostic vitamin-linker-taxoid conjugatesA peptide nucleic acid-functionalized carbon nitride nanosheet as a probe for in situ monitoring of intracellular microRNA.In vivo quantitation of rare circulating tumor cells by multiphoton intravital flow cytometrySynthesis and Evaluation of (99m)Tc-Labeled Folate-Tripeptide Conjugate as a Folate Receptor-Targeted Imaging Agent in a Tumor-Bearing Mouse ModelRNA nanoparticle as a vector for targeted siRNA delivery into glioblastoma mouse model.Folate-conjugated rapamycin slows progression of polycystic kidney diseaseExamining expression of folate receptor in squamous cell carcinoma of the head and neck as a target for a novel nanotherapeutic drug.Intraoperative imaging in ovarian cancer: fact or fiction?Patient selection and targeted treatment in the management of platinum-resistant ovarian cancer.Clinical pharmacokinetics and exposure-toxicity relationship of a folate-Vinca alkaloid conjugate EC145 in cancer patientsMR imaging of ovarian tumors using folate-receptor-targeted contrast agentsStrategy to prevent drug-related hypersensitivity in folate-targeted hapten immunotherapy of cancerAcetazolamide Serves as Selective Delivery Vehicle for Dipeptide-Linked Drugs to Renal Cell CarcinomaTargeted treatment of folate receptor-positive platinum-resistant ovarian cancer and companion diagnostics, with specific focus on vintafolide and etarfolatide.EC145: a novel targeted agent for adenocarcinoma of the lung.GPI transamidase and GPI anchored proteins: oncogenes and biomarkers for cancer.Modular nanotransporters for targeted intracellular delivery of drugs: folate receptors as potential targets.Role of the folate receptor in ovarian cancer treatment: evidence, mechanism, and clinical implications.Targeting the folate receptor: diagnostic and therapeutic approaches to personalize cancer treatments.Development of a New Folate-Derived Ga-68-Based PET Imaging Agent.Synthesis and biological evaluation of (68) Ga-labeled Pteroyl-Lys conjugates for folate receptor-targeted tumor imaging.Small Molecules for Active Targeting in Cancer.Direct in vivo evidence of activated macrophages in human osteoarthritis.Improved PET imaging of tumors in mice using a novel (18) F-folate conjugate with an albumin-binding entity.Synthesis, characterization, and in vitro assay of folic acid conjugates of 3'-azido-3'-deoxythymidine (AZT): toward targeted AZT based anticancer therapeutics.FolamiRs: Ligand-targeted, vehicle-free delivery of microRNAs for the treatment of cancer.In-vivo monitoring of anti-folate therapy in arthritic rats using [18F]fluoro-PEG-folate and positron emission tomography.Effect of chelators on the pharmacokinetics of (99m)Tc-labeled imaging agents for the prostate-specific membrane antigen (PSMA).RNA Nanoparticle-Based Targeted Therapy for Glioblastoma through Inhibition of Oncogenic miR-21.Folate-conjugated liposomes target and deliver therapeutics to immune cells in a rat model of rheumatoid arthritis.Leukemia-specific delivery of mutant NOTCH1 targeted therapy.Accessing Structurally Diverse Near-Infrared Cyanine Dyes for Folate Receptor-Targeted Cancer Cell Staining.A Dual-Targeting Octaguanidine-Doxorubicin Conjugate Transporter for Inducing Caspase-Mediated Apoptosis on Folate-Expressing Cancer Cells.Cationic folate-mediated liposomal delivery of bis-arylidene oxindole induces efficient melanoma tumor regression.Global financial challenge: opportunities for strengthening R&D research in targeted drug delivery.
P2860
Q26744215-2808D4F2-F827-4508-BCFD-FBA04EC804A1Q33627894-72FF48B3-829E-45DC-92F8-9043B2FD42BFQ33681146-D04B85BF-DE7F-43DC-B3AA-430EF085CB91Q35057527-7CE66F6E-AFE2-41DF-849C-0CC7A2CDA567Q35129324-EB1554D7-C805-450A-9DA4-AB112DA0EAE6Q35175462-0CC4806B-EA76-46B2-B740-52A9B32C6FE5Q35617391-87062E6D-A39A-46E0-B981-CEBBB45375A2Q35880206-59E18A6F-6777-4A74-9E83-9A039A99A2EEQ35941143-8C1B8863-338A-49B3-9A19-2B8A9945873DQ36020835-68FCCCA0-3003-435D-B987-A548F10FD913Q36280381-C351FBF8-E1B6-4382-92E5-AAFA5746FCA0Q37135687-C4DC423F-CAED-4A57-BA83-06CC10249865Q37149571-0722731D-0F6C-41F4-AAEE-FE62F6698389Q37220528-4CCD88DB-2871-48BE-B5A2-C99CE2FC4222Q37252523-332F0028-F523-4600-AC9A-9B375B5E8361Q37350412-396F0668-FC67-4E09-A3F7-620CB3D155BDQ37378084-633815E2-B8B7-4CFF-9CA0-680A73CF18C9Q37559487-2CFE82CC-06DA-4964-A50B-6003AD88B59AQ37567078-9DB63EA0-79BE-437F-A552-DCF78F0A2C37Q37998528-E96F07A6-23A7-406A-A7B2-278D55EC7EEAQ38131553-BA288DC1-F9BC-4CDD-B932-26D273822812Q38259956-F262A189-C7D5-42C8-A60A-A7048BA81F17Q38309549-18222975-C38F-42BE-BEFD-B152ABFA0A55Q38524502-751CC20A-7FDA-4259-BFF1-144141A9FAB9Q38716580-938BB195-5F3B-4621-9780-5544C7C8B037Q38763433-46A3B39D-49B0-44DF-9FEE-567692B8C593Q38780383-5C6FA2A5-DA01-4152-9CD7-B85269A8DC3AQ38809643-65EB674D-CEF1-474B-9DCF-91B67A22EEEAQ39140346-1F117521-8451-440C-AADE-57B9C493F148Q40023090-2C157AAE-CFD7-46EE-B49D-19A86D89269EQ41557167-0435E939-25F1-4BE1-8E6B-B72BDB192C0EQ41808297-3E1B6215-CF4B-4520-BACA-24A7C97788BCQ42620151-9FE5B720-BBAD-427E-A364-747C3C277D84Q45863841-3FBAA86E-579C-44D0-96C4-D9084E1A20BBQ47607208-84D51EBE-CA56-48E6-92B6-2B04B61BA479Q48268467-87AD3C06-4831-466D-A94A-15044F9AF829Q48364996-894635E6-90F0-4E6C-B456-61AE4D847774Q50248110-5797662C-5890-4D5A-B510-B4BCC968908BQ50886544-9E54A52B-358D-4695-9D77-3A7AB7A5C6DBQ51650648-30F51EED-0483-4B93-A318-CBED24F159C5
P2860
Synthesis and biological evaluation of EC20: a new folate-derived, (99m)Tc-based radiopharmaceutical.
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Synthesis and biological evalu ...... )Tc-based radiopharmaceutical.
@ast
Synthesis and biological evalu ...... )Tc-based radiopharmaceutical.
@en
Synthesis and biological evalu ...... )Tc-based radiopharmaceutical.
@nl
type
label
Synthesis and biological evalu ...... )Tc-based radiopharmaceutical.
@ast
Synthesis and biological evalu ...... )Tc-based radiopharmaceutical.
@en
Synthesis and biological evalu ...... )Tc-based radiopharmaceutical.
@nl
prefLabel
Synthesis and biological evalu ...... )Tc-based radiopharmaceutical.
@ast
Synthesis and biological evalu ...... )Tc-based radiopharmaceutical.
@en
Synthesis and biological evalu ...... )Tc-based radiopharmaceutical.
@nl
P2093
P356
P1476
Synthesis and biological evalu ...... )Tc-based radiopharmaceutical.
@en
P2093
Christopher P Leamon
Iontcho R Vlahov
Joseph A Reddy
Marilynn Vetzel
Matthew A Parker
Nikki Douglas
P304
P356
10.1021/BC0200430
P577
2002-11-01T00:00:00Z